ΠΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄-ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠΈΠΉ 130ΠΊΠΠ° Π±Π΅Π»ΠΎΠΊ ΠΈΠ· Π³Π»Π°Π΄ΠΊΠΎΠΌΡΡΠ΅ΡΠ½ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΡΠΎΡΡΠ΄ΠΎΠ² ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°: ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ, ΡΠ°ΡΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π² ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π΅ ΠΈ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ
Π Π·Π°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠΈ, Ρ Ρ ΠΎΡΡ Π²ΡΡΠ°Π·ΠΈΡΡ Π³Π»ΡΠ±ΠΎΠΊΡΡ Π±Π»Π°Π³ΠΎΠ΄Π°ΡΠ½ΠΎΡΡΡ ΡΠ²ΠΎΠΈΠΌ Π½Π°ΡΡΠ½ΡΠΌ ΡΡΠΊΠΎΠ²ΠΎΠ΄ΠΈΡΠ΅Π»ΡΠΌ ΠΡΠ΅Π²ΠΎΠ»ΠΎΠ΄Ρ ΠΡΡΠ΅Π½ΡΠ΅Π²ΠΈΡΡ Π’ΠΊΠ°ΡΡΠΊΡ ΠΈ ΠΠ°Π»Π΅ΡΠΈΡ ΠΠΈΠΊΠΎΠ»Π°Π΅Π²ΠΈΡΡ ΠΠΎΡΠΊΠΎΠ²Ρ, Π·Π° Π²ΡΠ΅, ΡΠ΅ΠΌΡ Ρ Ρ Π½ΠΈΡ Π½Π°ΡΡΠΈΠ»ΡΡ, Π·Π° Π²Π½ΠΈΠΌΠ°ΡΠ΅Π»ΡΠ½ΠΎΠ΅ ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠ΅, ΠΊΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π·Π°ΠΌΠ΅ΡΠ°Π½ΠΈΡ ΠΈ ΡΠΎΠ²Π΅ΡΡ ΠΏΡΠΈ ΠΏΠΎΠ΄Π³ΠΎΡΠΎΠ²ΠΊΠ΅ ΠΈ Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ Π΄ΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΠΈ, ΠΠ°ΡΠΈΠΈ ΠΠ°Π²Π»ΠΎΠ²Π½Π΅ Π€ΠΈΠ»ΠΈΠΏΠΏΠΎΠ²ΠΎΠΉ ΠΈ ΠΠ»Π΅Π½Π΅ Π‘ΡΠ΅ΠΏΠ°Π½ΠΎΠ²Π½Π΅ ΠΡΠ·ΡΠΌΠ΅Π½ΠΊΠΎ Π·Π° ΠΏΠΎΠΌΠΎΡΡ Π² Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΠΈ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠΎΠ², Π²ΡΠ΅ΠΌ ΡΠΎΡΡΡΠ΄Π½ΠΈΠΊΠ°ΠΌ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠΈΠΉ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- Π‘ΠΏΠΈΡΠΎΠΊ ΡΠΎΠΊΡΠ°ΡΠ΅Π½ΠΈΠΉ
- ΠΠΠΠΠ ΠΠΠ’ΠΠ ΠΠ’Π£Π Π«
- 1. ΠΠΎΠ»Π΅ΠΊΡΠ»Ρ ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ Π°Π΄Π³Π΅Π·ΠΈΠΈ
- 1. 1. ΠΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½ΠΎΠ²ΠΎΠ΅ ΡΡΠΏΠ΅ΡΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²ΠΎ
- 1. 2. ΠΠ½ΡΠ΅Π³ΡΠΈΠ½ΠΎΠ²ΠΎΠ΅ ΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²ΠΎ
- 1. 3. Π‘Π΅Π»Π΅ΠΊΡΠΈΠ½ΠΎΠ²ΠΎΠ΅ ΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²ΠΎ
- 1. 4. ΠΠ°Π΄Π³Π΅ΡΠΈΠ½ΠΎΠ²ΠΎΠ΅ ΡΡΠΏΠ΅ΡΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²ΠΎ
- 1. 4. 1. ΠΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Ρ
- 1. 4. 2. ΠΠ΅ΡΠΌΠΎΡΠΎΠΌΠ°Π»ΡΠ½ΡΠ΅ ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Ρ
- 1. 4. 3. ΠΡΠΎΡΠΎΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Ρ ΠΈ ΡΠΎΠ΄ΡΡΠ²Π΅Π½Π½ΡΠ΅ ΠΏΡΠΎΡΠΎΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π°ΠΌ Π±Π΅Π»ΠΊΠΈ
- 1. 4. 4. Π ΠΎΠ΄ΡΡΠ²Π΅Π½Π½ΡΠ΅ ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π°ΠΌ Π±Π΅Π»ΠΊΠΈ
- 1. 4. 5. Π£ΡΠ°ΡΡΠΈΠ΅ ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½ΠΎΠ² Π² ΡΠΈΠ³Π½Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ
- 1. 5. Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½
- 2. ΠΠ€Π-Π±Π΅Π»ΠΊΠΈ
- 2. 1. Π£ΡΠ°ΡΡΠΈΠ΅ ΠΠ€Π-Π±Π΅Π»ΠΊΠΎΠ² Π² ΡΠΈΠ³Π½Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ
- 2. 2. ΠΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΠ΅ ΡΡΠ°ΡΡΠΈΠ΅ ΠΠ€Π-Π±Π΅Π»ΠΊΠΎΠ² Π² ΡΠ΅Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ Π³ΠΎΡΠΌΠΎΠ½ΠΎΠΏΠΎΠ΄ΠΎΠ±Π½ΡΡ ΡΡΡΠ΅ΠΊΡΠΎΠ² Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄ΠΎΠ²
- 3. Π£ΡΠ°ΡΡΠΊΠΈ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Ρ Π±ΠΎΠ³Π°ΡΡΠ΅ Π³Π»ΠΈΠΊΠΎΠ»ΠΈΠΏΠΈΠ΄Π°ΠΌΠΈ ΠΈ Ρ
ΠΎΠ»Π΅ΡΡΠ΅ΡΠΈΠ½ΠΎΠΌ
- 3. 1. ΠΠ°Π²Π΅ΠΎΠ»Ρ ΠΈ ΠΊΠ°Π²Π΅ΠΎΠ»ΠΈΠ½
- 3. 2. ΠΠ±Π½Π°ΡΡΠΆΠ΅Π½Π½ΡΠ΅ Π² ΡΠΎΡΡΠ°Π²Π΅ ΠΊΠ°Π²Π΅ΠΎΠ» ΡΠΈΠ³Π½Π°Π»ΡΠ½ΡΠ΅ ΠΌΠΎΠ»Π΅ΠΊΡΠ»Ρ
- ΠΠΠ‘ΠΠΠ ΠΠΠΠΠ’ΠΠΠ¬ΠΠΠ― Π§ΠΠ‘Π’
- 1. ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ
- 1. 1. ΠΡΠ»ΡΡΠΈΠ²ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΊΠ»Π΅ΡΠΎΠΊ
- 1. 2. ΠΡΠ΄Π΅Π»Π΅Π½ΠΈΠ΅ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄ΠΎΠ²
- 1. 3. ΠΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΠΏΠΎΠ»ΠΈΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΡΡ Π°Π½ΡΠΈΡΠ΅Π» Π½Π° ΠΠΠ
- 1. 4. ΠΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ Fab-ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² Π°Π½ΡΠΈΡΠ΅Π»
- 1. 5. ΠΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΠΊΠΎΠ½ΡΡΠ³Π°ΡΠΎΠ² ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΠ΅ΠΏΡΠΈΠ΄ΠΎΠ² Ρ ΠΏΠ΅ΡΠΎΠΊΡΠΈΠ΄Π°Π·ΠΎΠΉ Ρ ΡΠ΅Π½Π°
- 1. 6. ΠΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΠΏΠΎΠ»ΠΈΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΡΡ
Π°Π½ΡΠΈΡΠ΅Π» ΠΏΡΠΎΡΠΈΠ² ΠΏΠ΅ΠΏΡΠΈΠ΄ΠΎΠ² Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π°
- 1. 6. 1. ΠΠΌΠΌΡΠ½ΠΈΠ·Π°ΡΠΈΡ ΠΊΡΠΎΠ»ΠΈΠΊΠΎΠ²
- 1. 6. 2. ΠΠΌΠΌΡΠ½ΠΈΠ·Π°ΡΠΈΡ ΠΌΡΡΠ΅ΠΉ
- 1. 7. ΠΠ»Π΅ΠΊΡΡΠΎΡΠΎΡΠ΅Π· Π±Π΅Π»ΠΊΠΎΠ² Π² ΠΏΠΎΠ»ΠΈΠ°ΠΊΡΠΈΠ»Π°ΠΌΠΈΠ΄Π½ΠΎΠΌ Π³Π΅Π»Π΅ Π² ΠΏΡΠΈΡΡΡΡΡΠ²ΠΈΠΈ Π΄ΠΎΠ΄Π΅ΡΠΈΠ» -ΡΡΠ»ΡΡΠ°ΡΠ° Π½Π°ΡΡΠΈΡ, Π»ΠΈΠ³Π°Π½Π΄Π½ΡΠΉ Π±Π»ΠΎΡΡΠΈΠ½Π³ ΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠ±Π»ΠΎΡΡΠΈΠ½Π³
- 1. 8. ΠΠΎΠ½ΡΡΠ³ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π°Π½ΡΠΈΡΠ΅Π» Ρ ΠΏΠ΅ΡΠΎΠΊΡΠΈΠ΄Π°Π·ΠΎΠΉ Ρ ΡΠ΅Π½Π°
- 1. 9. ΠΡΠ΄Π΅Π»Π΅Π½ΠΈΠ΅ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄-ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠ΅Π³ΠΎ Π±Π΅Π»ΠΊΠ° 130 ΠΊΠΠ° (Ρ130) ΠΈΠ· ΠΌΠ΅Π΄ΠΈΠΈ Π°ΠΎΡΡΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°
- 1. 9. 1. ΠΡΠ΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΠΌΠ΅Π΄ΠΈΠΈ Π°ΠΎΡΡΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°
- 1. 9. 2. Π‘ΠΎΠ»ΡΠ±ΠΈΠ»ΠΈΠ·Π°ΡΠΈΡ Π±Π΅Π»ΠΊΠΎΠ² ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΠΌΠ΅Π΄ΠΈΠΈ Π°ΠΎΡΡΡ Π΄Π΅ΡΠ΅ΡΠ³Π΅Π½ΡΠΎΠΌ CHAPS
- 1. 9. 3. ΠΠΎΠ½ΠΎΠΎΠ±ΠΌΠ΅Π½Π½Π°Ρ Ρ ΡΠΎΠΌΠ°ΡΠΎΠ³ΡΠ°ΡΠΈΡ Π½Π° DEAE-Toyopearl
- 1. 9. 4. Zn2+ -Ρ Π΅Π»Π°ΡΠ½Π°Ρ Ρ ΡΠΎΠΌΠ°ΡΠΎΠ³ΡΠ°ΡΠΈΡ
- 1. 9. 5. ΠΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈΠ²Π½ΡΠΉ ΡΠ»Π΅ΠΊΡΡΠΎΡΠΎΡΠ΅Π· Π² ΠΏΠΎΠ»ΠΈΠ°ΠΊΡΠΈΠ»Π°ΠΌΠΈΠ΄Π½ΠΎΠΌ Π³Π΅Π»Π΅ Π² ΠΏΡΠΈΡΡΡΡΡΠ²ΠΈΠΈ Π΄ΠΎΠ΄Π΅ΡΠΈΠ»ΡΡΠ»ΡΡΠ°ΡΠ° Π½Π°ΡΡΠΈΡ
- 1. 9. 6. ΠΠ»Π΅ΠΊΡΡΠΎΡΠ»ΡΡΠΈΡ Π±Π΅Π»ΠΊΠΎΠ² ΠΈΠ· ΠΏΠΎΠ»ΠΈΠ°ΠΊΡΠΈΠ»Π°ΠΌΠΈΠ΄Π½ΠΎΠ³ΠΎ Π³Π΅Π»Ρ
- 1. 9. 7. ΠΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈΠ²Π½Π°Ρ ΠΈΠ·ΠΎΡΠ»Π΅ΠΊΡΡΠΎΡΠΎΠΊΡΡΠΈΡΠΎΠ²ΠΊΠ°
- 1. 10. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠ°ΡΡΠΈΡΠ½ΠΎΠΉ Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΠΎΠΉ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π±Π΅Π»ΠΊΠ° Ρ
- 1. 11. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ Π±Π΅Π»ΠΊΠ°
- 1. 12. ΠΡΠ΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΠΊΡΠ»ΡΡΠΈΠ²ΠΈΡΡΠ΅ΠΌΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ
- 1. 13. ΠΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° ΡΡΠΈΡΠΎΠ½-Π½Π΅ΡΠ°ΡΡΠ²ΠΎΡΠΈΠΌΡΡ Π΄ΠΎΠΌΠ΅Π½ΠΎΠ² Π½ΠΈΠ·ΠΊΠΎΠΉ ΠΏΠ»ΠΎΡΠ½ΠΎΡΡΠΈ ΠΈΠ· ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΠΈ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΠΌΠ΅Π΄ΠΈΠΈ Π°ΠΎΡΡΡ
- 1. 14. ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ
- 2. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ
- 2. 1. ΠΡΠΈΡΡΠΊΠ° Π±Π΅Π»ΠΊΠ° Ρ130 ΠΈ Π΅Π³ΠΎ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ
- 2. 1. 1. ΠΡΠΈΡΡΠΊΠ° Ρ130 ΠΈΠ· ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΠΌΠ΅Π΄ΠΈΠΈ Π°ΠΎΡΡΡ
- 2. 1. 2. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠ°ΡΡΠΈΡΠ½ΠΎΠΉ Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΠΎΠΉ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π±Π΅Π»ΠΊΠ° Ρ
- 2. 2. ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ Π°Π½ΡΠΈΡΠ΅Π» Π΄Π»Ρ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ Π±Π΅Π»ΠΊΠ° Ρ
- 2. 2. 1. ΠΡΠ±ΠΎΡ Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΡΡ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΠ΅ΠΉ Π΄Π»Ρ ΠΏΠΎΠ»ΡΡΠ΅Π½ΠΈΡ Π°Π½ΡΠΈΡΠ΅Π» ΠΏΡΠΎΡΠΈΠ² ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² ΠΏΡΠΎ-Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π°
- 2. 2. 2. ΠΠΌΠΌΡΠ½ΠΎΠ±Π»ΠΎΡΡΠΈΠ½Π³ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° ΠΈΠ· ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΠΌΠ΅Π΄ΠΈΠΈ Π°ΠΎΡΡΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°, ΠΎΠ±ΠΎΠ³Π°ΡΠ΅Π½Π½ΠΎΠ³ΠΎ Ρ130 ΠΈ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½ΠΎΠΌ ΠΈ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΠΊΡΠ»ΡΡΠΈΠ²ΠΈΡΡΠ΅ΠΌΡΡ ΠΠΠ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ Π°Π½ΡΠΈΠΏΠ΅ΠΏΡΠΈΠ΄Π½ΡΡ Π°Π½ΡΠΈΡΠ΅Π»
- 2. 2. 3. ΠΠ»ΠΈΡΠ½ΠΈΠ΅ ΠΊΡΠΎΠ»ΠΈΡΡΠΈΡ ΠΏΠΎΠ»ΠΈΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΡΡ Π°Π½ΡΠΈΡΠ΅Π» ΠΏΡΠΎΡΠΈΠ² ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π° Π½Π° ΡΠ²ΡΠ·ΡΠ²Π°Π½ΠΈΠ΅ ΠΠΠ Ρ ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½ΠΎΠΌ ΠΈ Ρ130 ΠΏΡΠΈ Π»ΠΈΠ³Π°Π½Π΄Π½ΠΎΠΌ (ΠΠΠ-) Π±Π»ΠΎΡΡΠΈΠ½Π³Π΅
- 2. 2. 4. ΠΠ»ΠΈΡΠ½ΠΈΠ΅ Fab-ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² Π°Π½ΡΠΈΡΠ΅Π» ΠΏΡΠΎΡΠΈΠ² Π°ΠΏΠΎ-Π100 Π½Π° ΡΠ²ΡΠ·ΡΠ²Π°Π½ΠΈΠ΅ ΠΠΠ Ρ Ρ130 ΠΈ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½ΠΎΠΌ
- 2. 3. ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ΅ΡΠΌΠ΅Π½ΡΠ°ΡΠΈΠ²Π½ΠΎΠΉ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠΈ ΠΊΡΠ»ΡΡΠΈΠ²ΠΈΡΡΠ΅ΠΌΡΡ
ΠΠΠ ΠΈΠ· ΡΠΎΡΡΠ΄ΠΎΠ² ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° Π΄Π»Ρ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ Π±Π΅Π»ΠΊΠ° Ρ
- 2. 3. 1. ΠΠ±ΡΠ°Π±ΠΎΡΠΊΠ° ΠΊΠ»Π΅ΡΠΎΠΊ, ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΡΡΡΠΈΡ Ρ130 ΠΈ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½, ΡΡΠΈΠΏΡΠΈΠ½ΠΎΠΌ Π² ΠΏΡΠΈΡΡΡΡΡΠ²ΠΈΠΈ ΠΊΠ°Π»ΡΡΠΈΡ
- 2. 3. 2. ΠΠ±ΡΠ°Π±ΠΎΡΠΊΠ° ΠΊΠ»Π΅ΡΠΎΠΊ, ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΡΡΡΠΈΡ Ρ130 ΠΈ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½, ΠΠ€Π-ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ½ΠΎΠΉ ΡΠΎΡΡΠΎΠ»ΠΈΠΏΠ°Π·ΠΎΠΉ Π‘
- 2. 4. ΠΠ»ΠΈΡΠ½ΠΈΠ΅ ΡΡΠ²ΠΎΡΠΎΡΠΊΠΈ ΠΈ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΎΡΡΠ° Π½Π° ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Ρ130 ΠΈ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π° Π² ΠΊΡΠ»ΡΡΠΈΠ²ΠΈΡΡΠ΅ΠΌΡΡ
ΠΠΠ ΠΈΠ· ΠΌΠ΅Π΄ΠΈΠΈ Π°ΠΎΡΡΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°
- 2. 4. 1. ΠΠ»ΠΈΡΠ½ΠΈΡ ΡΡΠ²ΠΎΡΠΎΡΠΊΠΈ Π½Π° ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Ρ130 ΠΈ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π° Π² ΠΊΡΠ»ΡΡΠΈΠ²ΠΈΡΡΠ΅ΠΌΡΡ ΠΠΠ ΠΈΠ· ΠΌΠ΅Π΄ΠΈΠΈ Π°ΠΎΡΡΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°
- 2. 4. 2. ΠΠ»ΠΈΡΠ½ΠΈΡ Ρ ΠΎΠ»Π΅ΡΡΠ΅ΡΠΈΠ½Π° Π½Π° ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Ρ130 ΠΈ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π° Π² ΠΊΡΠ»ΡΡΠΈΠ²ΠΈΡΡΠ΅ΠΌΡΡ ΠΠΠ ΠΈΠ· ΠΌΠ΅Π΄ΠΈΠΈ Π°ΠΎΡΡΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°
- 2. 4. 3. ΠΠ»ΠΈΡΠ½ΠΈΡ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄-Π΄Π΅ΡΠΈΡΠΈΡΠ½ΠΎΠΉ ΡΡΠ²ΠΎΡΠΎΡΠΊΠΈ Π½Π° ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Ρ130 ΠΈ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π° Π² ΠΊΡΠ»ΡΡΠΈΠ²ΠΈΡΡΠ΅ΠΌΡΡ ΠΠΠ ΠΈΠ· ΠΌΠ΅Π΄ΠΈΠΈ Π°ΠΎΡΡΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°
- 2. 4. 4. ΠΠ»ΠΈΡΠ½ΠΈΡ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΎΡΡΠ° Π½Π° ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Ρ130 Π² ΠΊΡΠ»ΡΡΠΈΠ²ΠΈΡΡΠ΅ΠΌΡΡ ΠΠΠ ΠΈΠ· ΠΌΠ΅Π΄ΠΈΠΈ Π°ΠΎΡΡΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°
- 2. 4. 5. ΠΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ Ρ130 ΠΈ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈ-Π½Π° Π² ΠΊΡΠ»ΡΡΠΈΠ²ΠΈΡΡΠ΅ΠΌΡΡ ΠΠΠ ΠΈΠ· ΠΌΠ΅Π΄ΠΈΠΈ Π°ΠΎΡΡΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° ΠΏΠΎΠ΄ Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ΠΌ ΡΡΠ²ΠΎΡΠΎΡΠΊΠΈ ΠΈ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΎΡΡΠ°
- 2. 5. ΠΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΡ Ρ130 ΠΈ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π° Π² ΠΊΠ°Π²Π΅ΠΎΠ»ΡΡΠ½ΡΡ
ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΡΡ
Π΄ΠΎΠΌΠ΅Π½Π°Ρ
- 2. 5. 1. ΠΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΡ Ρ130 ΠΈ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π° Π² Π½Π΅ΡΠ°ΡΡΠ²ΠΎΡΠΈΠΌΡΡ Π² ΡΡΠΈΡΠΎΠ½Π΅ Π₯-100 ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΡΡ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ°Ρ Π½ΠΈΠ·ΠΊΠΎΠΉ ΠΏΠ»ΠΎΡΠ½ΠΎΡΡΠΈ
- 2. 5. 2. ΠΠΎΠ»ΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΡ Ρ130 ΠΈ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π° Π² ΠΊΠ°Π²Π΅ΠΎΠ»ΡΡΠ½ΡΡ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π°Ρ Ρ ΠΌΠΎΠ»Π΅ΠΊΡΠ»Π°ΠΌΠΈ, ΡΡΠ°ΡΡΠ²ΡΡΡΠΈΠΌΠΈ Π² ΡΠΈΠ³Π½Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ
- 2. 1. ΠΡΠΈΡΡΠΊΠ° Π±Π΅Π»ΠΊΠ° Ρ130 ΠΈ Π΅Π³ΠΎ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ
ΠΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄-ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠΈΠΉ 130ΠΊΠΠ° Π±Π΅Π»ΠΎΠΊ ΠΈΠ· Π³Π»Π°Π΄ΠΊΠΎΠΌΡΡΠ΅ΡΠ½ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΡΠΎΡΡΠ΄ΠΎΠ² ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°: ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ, ΡΠ°ΡΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π² ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π΅ ΠΈ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ (ΡΠ΅ΡΠ΅ΡΠ°Ρ, ΠΊΡΡΡΠΎΠ²Π°Ρ, Π΄ΠΈΠΏΠ»ΠΎΠΌ, ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½Π°Ρ)
ΠΠΎΠ»Π³ΠΎΠ΅ Π²ΡΠ΅ΠΌΡ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄Ρ ΠΏΠ»Π°Π·ΠΌΡ ΠΊΡΠΎΠ²ΠΈ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°Π»ΠΈΡΡ ΡΠΎΠ»ΡΠΊΠΎ ΠΊΠ°ΠΊ ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ½Π°Ρ ΡΠΈΡΡΠ΅ΠΌΠ° Π΄Π»Ρ ΠΏΠ΅ΡΠ΅Π½ΠΎΡΠ° Π»ΠΈΠΏΠΈΠ΄ΠΎΠ² Π² ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ΅.
ΠΠ΄Π½Π°ΠΊΠΎ ΠΊ Π½Π°ΡΡΠΎΡΡΠ΅ΠΌΡ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ Π½Π°ΠΊΠΎΠΏΠΈΠ»ΠΎΡΡ ΠΌΠ½ΠΎΠ³ΠΎ Π΄Π°Π½Π½ΡΡ ΠΎ Π΄Π΅ΠΉΡΡΠ²ΠΈΠΈ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄ΠΎΠ² Π½Π° ΠΊΠ»Π΅ΡΠΊΡ, ΠΊΠΎΡΠΎΡΠΎΠ΅ Π½Π΅ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΠΎΠ±ΡΡΡΠ½Π΅Π½ΠΎ ΡΠΎΠ»ΡΠΊΠΎ ΠΏΠ΅ΡΠ΅Π½ΠΎΡΠΎΠΌ Π»ΠΈΠΏΠΈΠ΄ΠΎΠ². ΠΡΠ»ΠΎ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄Ρ Π²Π»ΠΈΡΡΡ Π½Π° ΡΠΎΠ½ΡΡ ΡΠΎΡΡΠ΄ΠΎΠ², Π΄Π΅ΠΉΡΡΠ²ΡΡ ΠΊΠ°ΠΊ Π½Π΅ΠΏΠΎΡΡΠ΅Π΄ΡΡΠ²Π΅Π½Π½ΠΎ Π½Π° Π³Π»Π°Π΄ΠΊΠΎΠΌΡΡΠ΅ΡΠ½ΡΠ΅ ΠΊΠ»Π΅ΡΠΊΠΈ [Galle et al., 1990; Kugiyama et al., 1990], ΡΠ°ΠΊ ΠΈ Π½Π° ΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠΉ [Cohen at al., 1988; Jacobs et al., 1990; Tomita et al. 1990], Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠΎΠ² [Beitz and Mest, 1986; Ardlie et al., 1989] ΠΈ ΠΌΠΎΠ½ΠΎΡΠΈΡΠΎΠ² [Quinn et al., 1987; Kelley et al., 1988; McMurray et al., 1993], ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠ΅ Π°ΠΊΡΠΈΠ²Π½ΡΡ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠΎΠ² Π°ΡΠ°Ρ ΠΈΠ΄ΠΎΠ½ΠΎΠ²ΠΎΠΉ ΠΊΠΈΡΠ»ΠΎΡΡ [Triau et al., 1988; Pomerantz et al., 1984; Buhler et al., 1991], ΡΠ΅ΠΊΡΠ΅ΡΠΈΡ ΡΡΡΡΠ°ΠΊΡΠ°Π½ΡΠ° Π°Π»ΡΠ²Π΅ΠΎΠ»ΠΎΡΠΈΡΠ°ΠΌΠΈ [Voyno-Yasenetskaya et al., 1993], ΡΠΈΠ½ΡΠ΅Π· ΡΡΠΏΠ΅ΡΠΎΠΊΡΠΈΠ΄-ΡΠ°Π΄ΠΈΠΊΠ°Π»Π° ΠΌΠ°ΠΊΡΠΎΡΠ°Π³Π°ΠΌΠΈ [Mohan and Jacobson, 1995]., ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΠ·ΠΌ ΡΠ°ΠΊΡΠΎΡΠ° Π°ΠΊΡΠΈΠ²Π°ΡΠΈΠΈ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠΎΠ² (PAF) [Stafforini et al., 1987; Ostermann et al., 1989], ΠΈΠΌΠΌΡΠ½Π½ΡΠΉ ΠΎΡΠ²Π΅Ρ [Kiessling et al., 1991; Huang et al., 1995; Hui et al., 1980] ΠΈ ΡΠ»Π΅ΠΊΡΡΠΎΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΡΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΡΠ΅ΡΠ΄ΡΠ° [Adamantidis et al., 1991], Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΊΠ»Π΅ΡΠΎΠΊ [Ozer et al., 1993; Weisser et al., 1993; Bjorkerud and Bjorkerud, 1994; Libby et al., 1985], ΡΠΈΠ½ΡΠ΅Π· ΠΠΠ ΠΈ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ Π±Π΅Π»ΠΊΠΎΠ² [Oikawa et al., 1987; Scott-Burden et al., 1989; Hahn et al., 1991; ΠΠΎ et al., 1995].
Π’Π°ΠΊΠΆΠ΅ Π±ΡΠ»ΠΎ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄Ρ, ΠΏΠΎΠ΄ΠΎΠ±Π½ΠΎ Π³ΠΎΡΠΌΠΎΠ½Π°ΠΌ Π°ΠΊΡΠΈΠ²ΠΈΡΡΡΡ ΡΠΈΡΡΠ΅ΠΌΡ Π²ΡΠΎΡΠΈΡΠ½ΡΡ ΠΏΠΎΡΡΠ΅Π΄Π½ΠΈΠΊΠΎΠ². ΠΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄Ρ Π°ΠΊΡΠΈΠ²ΠΈΡΡΡΡ ΡΠΎΡΡΠΎΠΈΠ½ΠΎΠ·ΠΈΡΠΈΠ΄Π½ΡΠΉ ΠΎΠ±ΠΌΠ΅Π½ [Bochkov et al., 1993; Voyno-Yasenetskaya et al., 1993; Mendez et al., 1990] ΠΈ Π²ΡΠ·ΡΠ²Π°ΡΡ Π²ΡΡ ΠΎΠ΄ ΠΊΠ°Π»ΡΡΠΈΡ ΠΈΠ· Π²Π½ΡΡΡΠΈΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ Π΄Π΅ΠΏΠΎ [Bochkov et al., 1991bBochkov et al., 1992] ΠΈ Π²Ρ ΠΎΠ΄ ΠΊΠ°Π»ΡΡΠΈΡ ΠΈΠ·Π²Π½Π΅ Π² ΠΊΠ»Π΅ΡΠΊΡ [Tan et al., 1993]. ΠΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄Ρ Π½Π΅Π³Π°ΡΠΈΠ²Π½ΠΎ Π²Π»ΠΈΡΡΡ Π½Π° ΡΠΈΠ½ΡΠ΅Π· ΡΠΈΠΊΠ»ΠΈΡΠ΅ΡΠΊΠΈΡ Π½ΡΠΊΠ»Π΅ΠΎΡΠΈΠ΄ΠΎΠ² [Parhami et al., 1993 Schmidt et al., 1990.
Bruckdorfer et al., 1984]. ΠΡΠ»ΠΎ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ Π² ΡΠ΅Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ Π³ΠΎΡΠΌΠΎΠ½ΠΎΠΏΠΎΠ΄ΠΎΠ±Π½ΡΡ ΡΡΡΠ΅ΠΊΡΠΎΠ² Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄ΠΎΠ² ΠΏΡΠΈΠ½ΠΈΠΌΠ°ΡΡ ΡΡΠ°ΡΡΠΈΠ΅ G-Π±Π΅Π»ΠΊΠΈ [ΠΠΎΡΠΊΠΎΠ² ΠΈ Π΄Ρ., 1994 Sachinidis et. al., 1997 Pian and Dobbs, 1997]. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄Ρ ΡΡΠΈΠΌΡΠ»ΠΈΡΡΡΡ Π°ΠΊΡΠΈΠ²Π°ΡΠΈΡ ΠΊΠΈΠ½Π°Π·Π½ΡΡ ΠΊΠ°ΡΠΊΠ°Π΄ΠΎΠ² [Sachinidis et. al., 1997; Kusuhara et al., 1997].
Π’Π°ΠΊΠΈΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠΌ Π±ΡΠ»ΠΎ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄Ρ ΡΡΠΈΠΌΡΠ»ΠΈΡΡΡΡ ΡΠΎΡΡΠΎΠΈΠ½ΠΎΠ·ΠΈΡΠΈΠ΄Π½ΡΠΉ ΠΎΠ±ΠΌΠ΅Π½, Π²ΡΠ·ΡΠ²Π°ΡΡ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ Π²Π½ΡΡΡΠΈΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΠΊΠ°Π»ΡΡΠΈΡ, ΠΊΠ°ΠΊ Π·Π° ΡΡΠ΅Ρ Π²ΡΡ ΠΎΠ΄Π° ΠΈΠ· Π²Π½ΡΡΡΠΈΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ Π΄Π΅ΠΏΠΎ, ΡΠ°ΠΊ ΠΈ Π·Π° ΡΡΠ΅Ρ Π²Ρ ΠΎΠ΄Π° ΠΊΠ°Π»ΡΡΠΈΡ Π² ΠΊΠ»Π΅ΡΠΊΡ, Π²Π»ΠΈΡΡΡ Π½Π° ΡΠΈΠ½ΡΠ΅Π· ΡΠΈΠΊΠ»ΠΈΡΠ΅ΡΠΊΠΈΡ Π½ΡΠΊΠ»Π΅ΠΎΡΠΈΠ΄ΠΎΠ². Π’Π°ΠΊΠΆΠ΅ Π±ΡΠ»ΠΎ ΠΏΡΠΎΠ΄Π΅ΠΌΠΎΠ½ΡΡΡΠΈΡΠΎΠ²Π°Π½ΠΎ, ΡΡΠΎ Π² Π½Π΅ΠΊΠΎΡΠΎΡΡΡ ΡΠ»ΡΡΠ°ΡΡ ΡΡΡΠ΅ΠΊΡΡ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄ΠΎΠ² ΠΎΠΏΠΎΡΡΠ΅Π΄ΡΡΡΡΡ G-Π±Π΅Π»ΠΊΠ°ΠΌΠΈ. ΠΡΠ»ΠΎ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ ΡΡΠ°ΡΡΠΈΠ΅ Π² ΡΠ΅Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΡΡΡΠ΅ΠΊΡΠΎΠ² Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄ΠΎΠ² ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ ΠΊΠΈΠ½Π°Π·Π½ΡΡ ΠΊΠ°ΡΠΊΠ°Π΄ΠΎΠ², ΡΡΠΎ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΠΎΠ±ΡΡΡΠ½ΠΈΡΡ Π²Π»ΠΈΡΠ½ΠΈΠ΅ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄ΠΎΠ² Π½Π° ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ Π±Π΅Π»ΠΊΠΎΠ² ΠΈ ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ ΠΏΡΠΎΠ»ΠΈΡΠ΅ΡΠ°ΡΠΈΡ.
ΠΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΡΠΈΠ³Π½Π°Π»Π° ΠΎΡ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄Π½ΠΎΠΉ ΡΠ°ΡΡΠΈΡΡ Π² ΠΊΠ»Π΅ΡΠΊΡ Π΄ΠΎ ΡΠΈΡ ΠΏΠΎΡ Π½Π΅ ΠΎΠΏΠΈΡΠ°Π½. Π ΡΠ°ΡΡΠ½ΠΎΡΡΠΈ, Π½Π΅ ΠΈΠ·Π²Π΅ΡΡΠ΅Π½ ΡΠ΅ΡΠ΅ΠΏΡΠΎΡ, ΠΎΠΏΠΎΡΡΠ΅Π΄ΡΡΡΠΈΠΉ Π³ΠΎΡΠΌΠΎΠ½ΠΎΠΏΠΎΠ΄ΠΎΠ±Π½ΡΠ΅ ΡΡΡΠ΅ΠΊΡΡ ΠΠΠ.
Π Π°Π½Π΅Π΅ Π½Π°ΠΌΠΈ Π±ΡΠ» ΠΎΠΏΠΈΡΠ°Π½ Π½ΠΎΠ²ΡΠΉ ΡΡΠ°ΡΡΠΎΠΊ ΡΠ²ΡΠ·ΡΠ²Π°Π½ΠΈΡ Π΄Π»Ρ ΠΠΠ Π½Π° ΡΠΎΡΡΠ΄ΠΈΡΡΡΡ ΠΠΠ. ΠΠ°ΡΠ°ΠΌΠ΅ΡΡΡ ΡΠ²ΡΠ·ΡΠ²Π°Π½ΠΈΡ ΠΠΠ Ρ ΠΊΠΎΡΠΎΡΡΠΌ, Ρ ΠΎΡΠΎΡΠΎ ΠΊΠΎΡΡΠ΅Π»ΠΈΡΠΎΠ²Π°Π»Π° Ρ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠ°ΠΌΠΈ Π°ΠΊΡΠΈΠ²Π°ΡΠΈΠΈ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄Π°ΠΌΠΈ ΡΠΈΡΡΠ΅ΠΌ Π²ΡΠΎΡΠΈΡΠ½ΡΡ ΠΏΠΎΡΡΠ΅Π΄Π½ΠΈΠΊΠΎΠ² [Tkachuk et al., 1994]. ΠΠ΅ΡΠΎΠ΄ΠΎΠΌ Π»ΠΈΠ³Π°Π½Π΄Π½ΠΎΠ³ΠΎ (ΠΠΠ-) Π±Π»ΠΎΡΡΠΈΠ½Π³Π° ΠΌΡ ΠΎΠ±Π½Π°ΡΡΠΆΠΈΠ»ΠΈ Π΄Π²Π° ΠΠΠ-ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠΈΡ Π±Π΅Π»ΠΊΠ° [Kuzmenko et al., 1994] ΠΈ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ, ΡΡΠΎ ΠΈΡ Π»ΠΈΠ³Π°Π½Π΄Π½Π°Ρ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ½ΠΎΡΡΡ ΠΎΡΠ»ΠΈΡΠ°Π΅ΡΡΡ ΠΎΡ ΡΠ°ΠΊΠΎΠ²ΠΎΠΉ ΠΈΠ·Π²Π΅ΡΡΠ½ΡΡ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄Π½ΡΡ ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΠΎΠ² [Bochkov et al., 1996]. Π Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠ΅ΠΌ ΠΌΡ ΠΎΡΠΈΡΡΠΈΠ»ΠΈ Π΄ΠΎ Π³ΠΎΠΌΠΎΠ³Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄-ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠΈΠΉ Π±Π΅Π»ΠΎΠΊ ΠΌΠ°ΡΡΠΎΠΉ 105 ΠΊΠΠ° ΠΈ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π»ΠΈ Π΅Π³ΠΎ ΠΊΠ°ΠΊ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½ — ΡΠ»Π΅Π½ ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½ΠΎΠ²ΠΎΠ³ΠΎ ΡΡΠΏΠ΅ΡΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²Π° [Tkachuk et al., 1998]. ΠΡΠΈΡΠΎΠ΄Π° 130 ΠΊΠΠ° ΠΠΠ-ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠ΅Π³ΠΎ Π±Π΅Π»ΠΊΠ° Π΄ΠΎ Π½Π°ΡΡΠΎΡΡΠ΅Π³ΠΎ ΠΌΠΎΠΌΠ΅Π½ΡΠ° ΠΎΡΡΠ°Π²Π°Π»Π°ΡΡ Π½Π΅Π²ΡΡΡΠ½Π΅Π½Π½ΠΎΠΉ. In vitro Π² ΠΈΡΠΊΡΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΈΠΈ (Π½Π° ΠΊΠ»Π΅ΡΠΊΠ°Ρ Ρ ΠΎΠΌΡΡΠΊΠ°, ΡΡΠ°Π½ΡΡΠ΅ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½ΠΎΠΌ ΠΊΡΡΠΈΡΡ) Π±ΡΠ»Π° ΠΏΠΎΠΊΠ°Π·Π°Π½Π° ΠΎΠ΄Π½ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½Π°Ρ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Π·ΡΠ΅Π»ΠΎΠΉ ΡΠΎΡΠΌΡ ΠΈ ΠΏΡΠ΅Π΄ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΈΠΊΠ° Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π° [Verstal and Ranscht, 1992]. ΠΡ ΠΏΡΠ΅Π΄ΠΏΠΎΠ»ΠΎΠΆΠΈΠ»ΠΈ, ΡΡΠΎ ΡΡΠΎ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎ ΠΈ in vivo, ΠΈ 130 ΠΊΠΠ° ΠΠΠ-ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠΈΠΉ Π±Π΅Π»ΠΎΠΊ ΠΈΠ· ΠΠΠ ΠΌΠ΅Π΄ΠΈΠΈ Π°ΠΎΡΡΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° ΠΌΠΎΠΆΠ΅Ρ ΠΎΠΊΠ°Π·Π°ΡΡΡΡ ΠΏΡΠ΅Π΄ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΈΠΊΠΎΠΌ Π·ΡΠ΅Π»ΠΎΠΉ ΡΠΎΡΠΌΡ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π°. ΠΠ·Π²Π΅ΡΡΠ½ΠΎ, ΡΡΠΎ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΠΎΠΉ ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ Π°Π΄Π³Π΅Π·ΠΈΠΈ, ΠΏΡΠΈΠΊΡΠ΅ΠΏΠ»Π΅Π½Π½ΠΎΠΉ ΠΊ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π΅ Ρ ΠΏΠΎΠΌΠΎΡΡΡ Π³Π»ΠΈΠΊΠΎΠ·ΠΈΠ»ΡΠΎΡΡΠΎΠΈΠ½ΠΎΠ·ΠΈΡΠΈΠ΄Π½ΠΎΠ³ΠΎ (ΠΠ€Π) — ΡΠΊΠΎΡΡ. Π Π½Π°ΡΡΠΎΡΡΠ΅ΠΌΡ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ ΡΡΠ°ΡΡΠΈΠ΅ ΠΌΠ½ΠΎΠ³ΠΈΡ ΠΌΠΎΠ»Π΅ΠΊΡΠ» ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ Π°Π΄Π³Π΅Π·ΠΈΠΈ [Rosales et al., 1995] ΠΈ ΠΏΡΠ΅Π΄ΠΏΠΎΠ»Π°Π³Π°Π΅ΡΡΡ ΡΡΠ°ΡΡΠΈΠ΅ Π½Π΅ΠΊΠΎΡΠΎΡΡΡ ΠΠ€Π-Π±Π΅Π»ΠΊΠΎΠ² (ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΠ° ΡΡΠΎΠΊΠΈΠ½Π°Π·Ρ ΠΈ CD 14) [Petty and Todd III, 1995] Π² ΠΏΡΠΎΡΠ΅ΡΡΠ°Ρ Π²Π½ΡΡΡΠΈΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ ΡΠΈΠ³Π½Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ. ΠΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΡ ΡΡΠΈΡ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² Π΄ΠΎ Π½Π°ΡΡΠΎΡΡΠ΅Π³ΠΎ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎ ΠΏΠΎΠ»Π½ΠΎ Π½Π΅ ΠΎΠΏΠΈΡΠ°Π½Ρ. ΠΡ ΠΏΡΠ΅Π΄ΠΏΠΎΠ»Π°Π³Π°Π΅ΠΌ, ΡΡΠΎ 130 ΠΊΠΠ° Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄-ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠΈΠΉ Π±Π΅Π»ΠΎΠΊ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΠΏΡΠ΅Π΄ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΈΠΊΠΎΠΌ Π·ΡΠ΅Π»ΠΎΠΉ ΡΠΎΡΠΌΡ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π° ΠΈ ΡΡΠΎ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎ ΠΏΡΠΈΠ½ΠΈΠΌΠ°Π΅Ρ ΡΡΠ°ΡΡΠΈΠ΅ Π² ΠΏΠ΅ΡΠ΅Π΄Π°ΡΠ΅ ΡΠΈΠ³Π½Π°Π»Π° ΠΎΡ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄ΠΎΠ² Π² ΠΊΠ»Π΅ΡΠΊΡ.
Π¦Π΅Π»ΡΡ Π΄Π°Π½Π½ΠΎΠΉ ΡΠ°Π±ΠΎΡΡ Π±ΡΠ»Π° Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΠΎΠ³ΠΎ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄-ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠ΅Π³ΠΎ Π±Π΅Π»ΠΊΠ°, ΠΈΠΌΠ΅ΡΡΠ΅Π³ΠΎ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΡ ΠΌΠ°ΡΡΡ 130 ΠΊΠΠ° Π² ΠΠΠ ΠΊΡΠΎΠ²Π΅Π½ΠΎΡΠ½ΡΡ ΡΠΎΡΡΠ΄ΠΎΠ² ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°. Π ΡΠ²ΡΠ·ΠΈ Ρ ΡΡΠΈΠΌ Π±ΡΠ»ΠΈ ΠΏΠΎΡΡΠ°Π²Π»Π΅Π½Ρ ΡΠ»Π΅Π΄ΡΡΡΠΈΠ΅ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΠ΅ Π·Π°Π΄Π°ΡΠΈ:
1. ΠΡΠ΄Π΅Π»ΠΈΡΡ, ΠΎΡΠΈΡΡΠΈΡΡ Π΄ΠΎ Π³ΠΎΠΌΠΎΠ³Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΠΈ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°ΡΡ ΠΏΡΡΠ΅ΠΌ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΡΠ°ΡΡΠΈΡΠ½ΠΎΠΉ Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΠΎΠΉ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄-ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠΈΠΉ Π±Π΅Π»ΠΎΠΊ Ρ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠΉ ΠΌΠ°ΡΡΠΎΠΉ 130 ΠΊΠΠ°.
2. ΠΠ·ΡΡΠΈΡΡ Π²Π»ΠΈΡΠ½ΠΈΠ΅ ΡΡΠ²ΠΎΡΠΎΡΠΊΠΈ ΠΈ Π΅Π΅ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠΎΠ² Π½Π° ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Π±Π΅Π»ΠΊΠ° Ρ130 ΠΈ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π° Π² ΡΠΎΡΡΠ΄ΠΈΡΡΡΡ ΠΠΠ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°.
3. ΠΠΎΠ»ΡΡΠΈΡΡ Π°Π½ΡΠΈΡΠ΅Π»Π° ΠΏΡΠΎΡΠΈΠ² Π±Π΅Π»ΠΊΠ° Ρ 130 ΠΈ Ρ ΠΈΡ ΠΏΠΎΠΌΠΎΡΡΡ Π²ΡΡΡΠ½ΠΈΡΡ Π΅Π³ΠΎ ΡΠ°ΡΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π² ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π΅.
ΠΠ±Π·ΠΎΡ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ.
ΠΡΠ²ΠΎΠ΄Ρ:
1. ΠΠ΅ΠΌΠ±ΡΠ°Π½Π½ΡΠΉ Π±Π΅Π»ΠΎΠΊ Ρ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠΉ ΠΌΠ°ΡΡΠΎΠΉ 130 ΠΊΠΠ° (Ρ 130) ΠΎΡΠΈΡΠ΅Π½ ΠΈΠ· ΡΠΊΠ°Π½ΠΈ ΠΌΠ΅Π΄ΠΈΠΈ Π°ΠΎΡΡΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° Π΄ΠΎ Π³ΠΎΠΌΠΎΠ³Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π° Π΅Π³ΠΎ ΡΠ°ΡΡΠΈΡΠ½Π°Ρ Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½Π°Ρ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΡ, ΡΠΎΠ²ΠΏΠ°Π΄Π°ΡΡΠ°Ρ Ρ ΡΠΈΠΊΠ²Π΅Π½ΡΠΎΠΌ ΠΏΡΠΎΠΏΠ΅ΠΏΡΠΈΠ΄Π½ΠΎΠ³ΠΎ ΡΡΠ°ΡΡΠΊΠ° ΠΏΡΠ΅Π΄ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΈΠΊΠ° Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π°.
2. ΠΠΎΠ»ΡΡΠ΅Π½Ρ ΠΈ ΠΎΡ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΠΎΠ²Π°Π½Ρ Π°Π½ΡΠΈΡΡΠ²ΠΎΡΠΎΡΠΊΠΈ ΠΏΡΠΎΡΠΈΠ² ΡΡΠ΅Ρ ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π°. ΠΡΠ΅ ΠΎΠ½ΠΈ ΡΠ°ΡΠΏΠΎΠ·Π½Π°ΡΡ ΠΊΠ°ΠΊ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½, ΡΠ°ΠΊ ΠΈ Ρ130. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π°Π½ΡΠΈΡΡΠ²ΠΎΡΠΎΡΠΊΠΈ Π±Π»ΠΎΠΊΠΈΡΡΡΡ ΡΠ²ΡΠ·ΡΠ²Π°Π½ΠΈΠ΅ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄ΠΎΠ² Ρ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½ΠΎΠΌ ΠΈ Ρ130.
3. ΠΠ΅Π»ΠΎΠΊ Ρ130 ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½ Π½Π° ΠΏΠΎΠ²Π΅ΡΡ Π½ΠΎΡΡΠΈ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΈ Π·Π°ΠΊΡΠ΅ΠΏΠ»Π΅Π½ Π½Π° ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π΅ ΠΏΠΎΡΡΠ΅Π΄ΡΡΠ²ΠΎΠΌ Π³Π»ΠΈΠΊΠΎΠ·ΠΈΠ»ΡΠΎΡΡΠ°ΡΠΈΠ΄ΠΈΠ»ΠΈΠ½ΠΎΠ·ΠΈΡΠΎΠ»ΡΠ½ΠΎΠΉ (ΠΠ€Π-) Π³ΡΡΠΏΠΏΡ, ΠΎ ΡΠ΅ΠΌ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΠ΅Ρ ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡ ΠΠ€Π-ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ½ΠΎΠΉ ΡΠΎΡΡΠΎΠ»ΠΈΠΏΠ°Π·Ρ ΠΎΡΡΠ΅ΠΏΠ»ΡΡΡ Π΅Π³ΠΎ ΠΎΡ Π³Π»Π°Π΄ΠΊΠΎΠΌΡΡΠ΅ΡΠ½ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ. ΠΠ³ΡΠ°Π½ΠΈΡΠ΅Π½Π½ΡΠΉ ΡΡΠΈΠΏΡΠΈΠ½ΠΎΠ»ΠΈΠ· Π² ΠΏΡΠΈΡΡΡΡΡΠ²ΠΈΠΈ Π‘Π°2+ ΠΏΡΠ΅Π²ΡΠ°ΡΠ°Π΅Ρ Ρ130 Π² Π±Π΅Π»ΠΎΠΊ, ΡΠΎΠ²ΠΏΠ°Π΄Π°ΡΡΠΈΠΉ ΠΏΠΎ ΡΠ»Π΅ΠΊΡΡΠΎΡΠΎΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΠ΄Π²ΠΈΠΆΠ½ΠΎΡΡΠΈ Ρ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½ΠΎΠΌ.
4. Π£ΡΠΎΠ²Π΅Π½Ρ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π° ΠΈ Ρ130 Π·Π°Π²ΠΈΡΠΈΡ ΠΎΡ ΡΡΠΈΠΌΡΠ»ΡΡΠΈΠΈ Π³Π»Π°Π΄ΠΊΠΎΠΌΡΡΠ΅ΡΠ½ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΡΠ°ΠΊΡΠΎΡΠ°ΠΌΠΈ ΡΠΎΡΡΠ°. Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΡΡΠΈΡ Π±Π΅Π»ΠΊΠΎΠ² ΠΏΠΎΠ²ΡΡΠ°Π΅ΡΡΡ Π² Π»ΠΈΡΠ΅Π½Π½ΡΡ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΎΡΡΠ° ΠΊΠ»Π΅ΡΠΊΠ°Ρ ΠΈ ΡΠ½ΠΈΠΆΠ°Π΅ΡΡΡ ΠΏΡΠΈ Π΄Π΅ΠΉΡΡΠ²ΠΈΠΈ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΎΡΡΠ°. Π£ΡΠΎΠ²Π΅Π½Ρ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π° ΠΈ Ρ 130 Π½Π΅ ΡΠ΅Π³ΡΠ»ΠΈΡΡΠ΅ΡΡΡ Ρ ΠΎΠ»Π΅ΡΡΠ΅ΡΠΈΠ½ΠΎΠΌ.
5. Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½ ΠΈ Ρ130 ΠΎΠ±ΠΎΠ³Π°ΡΠ΅Π½Ρ Π² ΡΡΠΈΡΠΎΠ½-Π½Π΅ΡΠ°ΡΡΠ²ΠΎΡΠΈΠΌΠΎΠΉ ΠΊΠ°Π²Π΅ΠΎΠ»ΡΡΠ½ΠΎΠΉ ΡΡΠ°ΠΊΡΠΈΠΈ ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½, ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠ΅ΠΉ ΠΎΠΊΠΎΠ»ΠΎ 0,1% ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ Π±Π΅Π»ΠΊΠ°. Π ΡΡΠΎΠΉ ΠΆΠ΅ ΡΡΠ°ΠΊΡΠΈΠΈ Π»ΠΎΠΊΠ°Π»ΠΈΠ·ΠΎΠ²Π°Π½Ρ Π-Π±Π΅Π»ΠΊΠΈ ΠΈ ΠΠ³Ρ-ΠΊΠΈΠ½Π°Π·Ρ, Π½ΠΎ ΠΎΡΡΡΡΡΡΠ²ΡΡΡ ΠΈΠ½ΡΠ΅Π³ΡΠΈΠ½Ρ ΠΈ ΠΊΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Ρ.
6. ΠΠ° ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠΈ ΠΏΡΠΈΠ²Π΅Π΄Π΅Π½Π½ΡΡ Π²ΡΡΠ΅ Π΄Π°Π½Π½ΡΡ ΡΠ΄Π΅Π»Π°Π½ΠΎ Π·Π°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅, ΡΡΠΎ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄-ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠΈΠΉ Π±Π΅Π»ΠΎΠΊ Ρ130 ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΠ€Π-Π·Π°ΡΠΊΠΎΡΠ΅Π½Π½ΡΠΌ ΠΏΡΠ΅Π΄ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΈΠΊΠΎΠΌ Π’-ΠΊΠ°Π΄Π³Π΅ΡΠΈΠ½Π°.
Π Π·Π°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠΈ, Ρ Ρ ΠΎΡΡ Π²ΡΡΠ°Π·ΠΈΡΡ Π³Π»ΡΠ±ΠΎΠΊΡΡ Π±Π»Π°Π³ΠΎΠ΄Π°ΡΠ½ΠΎΡΡΡ ΡΠ²ΠΎΠΈΠΌ Π½Π°ΡΡΠ½ΡΠΌ ΡΡΠΊΠΎΠ²ΠΎΠ΄ΠΈΡΠ΅Π»ΡΠΌ ΠΡΠ΅Π²ΠΎΠ»ΠΎΠ΄Ρ ΠΡΡΠ΅Π½ΡΠ΅Π²ΠΈΡΡ Π’ΠΊΠ°ΡΡΠΊΡ ΠΈ ΠΠ°Π»Π΅ΡΠΈΡ ΠΠΈΠΊΠΎΠ»Π°Π΅Π²ΠΈΡΡ ΠΠΎΡΠΊΠΎΠ²Ρ, Π·Π° Π²ΡΠ΅, ΡΠ΅ΠΌΡ Ρ Ρ Π½ΠΈΡ Π½Π°ΡΡΠΈΠ»ΡΡ, Π·Π° Π²Π½ΠΈΠΌΠ°ΡΠ΅Π»ΡΠ½ΠΎΠ΅ ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠ΅, ΠΊΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π·Π°ΠΌΠ΅ΡΠ°Π½ΠΈΡ ΠΈ ΡΠΎΠ²Π΅ΡΡ ΠΏΡΠΈ ΠΏΠΎΠ΄Π³ΠΎΡΠΎΠ²ΠΊΠ΅ ΠΈ Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ Π΄ΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΠΈ, ΠΠ°ΡΠΈΠΈ ΠΠ°Π²Π»ΠΎΠ²Π½Π΅ Π€ΠΈΠ»ΠΈΠΏΠΏΠΎΠ²ΠΎΠΉ ΠΈ ΠΠ»Π΅Π½Π΅ Π‘ΡΠ΅ΠΏΠ°Π½ΠΎΠ²Π½Π΅ ΠΡΠ·ΡΠΌΠ΅Π½ΠΊΠΎ Π·Π° ΠΏΠΎΠΌΠΎΡΡ Π² Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΠΈ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠΎΠ², Π²ΡΠ΅ΠΌ ΡΠΎΡΡΡΠ΄Π½ΠΈΠΊΠ°ΠΌ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠΈΠΉ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠΉ ΡΠ½Π΄ΠΎΠΊΡΠΈΠ½ΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈ ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ ΠΏΠΎΠ΄Π²ΠΈΠΆΠ½ΠΎΡΡΠΈ Π·Π° ΡΠ΅ΠΏΠ»ΠΎΠ΅ Π΄ΡΡΠΆΠ΅ΡΠΊΠΎΠ΅ ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠ΅, Π° ΡΠ°ΠΊΠΆΠ΅ Π. Π. ΠΠ΅ΡΠΏΠ°Π»ΠΎΠ²ΠΎΠΉ, Π. Π. Π‘ΠΈΠ΄ΠΎΡΠΎΠ²ΠΎΠΉ, A.C. ΠΠΎΠ»ΠΎΠΊΠΎΠ΅Π΄ΠΎΠ²Ρ, Π’. Π. ΠΠ»Π°ΡΠΈΠΊ, Π. Π. ΠΠ°ΡΠΈΡΠΈΠ½ΠΎΠΉ, Π. Π. Π‘ΠΏΠΈΡΠΎΠ²Ρ, Π. Π. Π’Π°ΡΠ°ΡΠ°ΠΊΡ, Π. Π. ΠΡΡΠ΅ΠΌΠΎΠ²Ρ ΠΈ Π΄ΡΡΠ³ΠΈΠΌ ΡΠΎΡΡΡΠ΄Π½ΠΈΠΊΠ°ΠΌ ΠΠΠΠΠ Π·Π° ΡΠ΅ΠΎΡΠ΅ΡΠΈΡΠ΅ΡΠΊΡΡ ΠΈ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΡΡ ΠΏΠΎΠΌΠΎΡΡ Π½Π° ΡΠ°Π·Π½ΡΡ ΡΡΠ°ΠΏΠ°Ρ Π΄Π°Π½Π½ΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ.
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠ²Π΄ΠΎΠ½ΠΈΠ½ Π.Π., Π’ΠΊΠ°ΡΡΠΊ Π. Π. (1994). Π Π΅ΡΠ΅ΠΏΡΠΎΡΡ ΠΈ Π²Π½ΡΡΡΠΈΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΉ ΠΊΠ°Π»ΡΡΠΈΠΉ. -«ΠΠ°ΡΠΊΠ°», ΠΠΎΡΠΊΠ²Π°.
- ΠΠΎΡΠΊΠΎΠ² Π.Π., ΠΡΠ·ΡΠΌΠ΅Π½ΠΊΠΎ ΠΠ‘., Π Π΅Π·ΠΈΠ½ΠΊ Π’., Π’ΠΊΠ°ΡΡΠΊ Π. Π. (1994). ΠΠΎΡΠΌΠΎΠ½ΠΎΠΏΠΎΠ΄ΠΎΠ±Π½ΡΠ΅ ΡΡΡΠ΅ΠΊΡΡ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄ΠΎΠ² ΠΏΠ»Π°Π·ΠΌΡ ΠΊΡΠΎΠ²ΠΈ Π½Π° ΡΠ΅Π»ΠΎΠ²Π΅ΡΠ΅ΡΠΊΠΈΠ΅ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΡ ΠΈ Π³Π»Π°Π΄ΠΊΠΎΠΌΡΡΠ΅ΡΠ½ΡΠ΅ ΠΊΠ»Π΅ΡΠΊΠΈ. ΠΠΈΠΎΡ ΠΈΠΌΠΈΡ 59(7): 958−966.
- Albelda S.M. (1993). Biology of disease. Role of Integrins and other cell adhesion molecules in tumor progression and metastasis. Laboratory Investigation 68(1): 4−17.
- Amagai M. (1995). Adhesion molecules. I: Keratinocyte keratinocyte interactions- Cadherins and pemphigus. J. Invest. Dermatology 104: 146−152.
- Ardlie N.G., Selley M.L., Simons L.A. (1989). Platelet activation by oxidatively modified low density lipoproteins. Atheroscler. 76: 117−124.
- Beitz J., Mest H.J. (1986). Thromboxane A2 (TXA2) formation by washed human platelets under the influence of low and high density lipoproteins from healthy donors. -Prostaglandins Leukot. Med. 23(2−3): 303−309.
- Besser D., Verde P., Nagamine Y., Blasi F. (1996). Signal transduction and the u-PA/u-PAR system. Fibrinolysis 10 (4): 215−237.
- Bist A., Fielding P.E., Fielding C.J. (1997). Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free chjlesterol. Proc. Natl. Acad. Sei. USA 94(20): 10 693−10 698.
- Bjorkerud S., Bjorkerud B. (1994). Lipoproteins are primary mitogens and growth promoters for human arterial smooth muscle cells and lung fibroblasts in vitro. -Arterioscler.Thromb. 14: 288−298.
- Blaschuk O.W., Pouliot Y., Holland P.C. (1990). Identification of a conserved region common to Cadherin and influenza strain A hemagglutinins. J. Mol. Biol. 211: 679−682.
- Bochkov V.N., Matchin Y.G., Fuki I.V., Lyakishev A.A., Tkachuk V.A., (1992a). Platelets in patients with homozygous familial hypercholesterolemia are sensitive to Ca2±mobolizing activity of low density lipoproteins. Atherosclerosis, 96: 119−124.
- Bochkov V.N., Tkachuk V.A., Buhler F.R., Resink T.J. (1992b). Phosphoinositide and calcium signalling responses in smooth muscle cells: comparison between lipoproteins, Ang II and PDGF. Biochem. Biophys. Res.Comm. 188: 1295−1304.
- Bochkov V.N., Tkachuk V.A., Hahn A.W.A., Bernhardt J., Buhler F.R., Resink T.J.1993). Concerted effaects of lipoproteins and angiotensin II on signal transduction processes in vascular smooth muscle cells. Arterioscl.Thromb. 13: 1261−1269.
- Bochkov V.N., Tkachuk V.A., Philippova M.P., Stambolsky D. and Resink T.J. (1996). Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth- muscle- cell membranes is unique. Biochem.J.3 17: 297−304.
- Brown M.S. and Goldstein J.L. (1975). Regultion of the activity of the low density lipoprotein receptor in human fibroblasts. Cell 6: 307−316.
- Bruckdorfer K.R., Buckley S., Hassall D.G. (1984). The effect of low density lipoproteins on the synthesis of cyclic nucleotides induced by prostacyclin in isolated platelets. Biochem.J. 223: 189−196.
- Buxton R.S. and Magee A.I. (1992). Structure and interactions of desmosomal and other cadherins. Seminars in Cell Biol. 3(3): 157−167.
- Catty D. (1989). Antibidies. A practical approach. IRL Press, Oxford Washington DC.
- Chan B.L., Chao M.V., Saltiel A.R. (1989). Nerve growth factor stimulates the hydrolysis of glycosyl-phosphatidylinositol in PC-12 cells: a mechanism of protein kinase regulation. Proc.Natl.Acad.Sci.USA 86: 1756−1760.
- Cheifetz S. and Massague J. (1991). Isoform-speciflc transforming growth factor-beta binding proteins with membrane attachments sensitive to phosphatidylinositol-specific phospholipase C. J. Biol. Chem. 266(31):20 767−20 772.
- Chun M., Liyanage U.K., Lisanti M.P., Lodish H.F. (1994). Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endotelin and its receptor with caveolin. Proc. Natl. Acad. Sci. USA 91(24): 11 728−11 732.
- Cohen R.A., Zitnay K.M., Weisbrod R.M., Tesfamariam B. (1988). Influence of the endothelium on tone and the response of isolated pig coronary artery to norepinephrine. -J. Pharmacol. Exp. Ther. 244(2): 550−555.
- Couet J., Sargiacomo M., Lisanti M.P. (1997). Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/thrtonine kinase activities. J Biol. Chem. 272(48): 30 429−30 438.
- Cowin P. (1994). Unraveling the cytoplasmic interactions of the cadherin superfamily. -Proc. Natl. Acad. Sci. USA91: 10 759−10 761.
- Doering T.L., Masterson W.J., Hart G.W. and Englund P. (1990). Biyosynthesis of glycosyl phosphatidylinositol membrane anchors. J. Biol. Chem. 265(2): 611−614.
- Doherty P., Ashton S.V., Moore S.E., Walsh F.S. (1991). Morphoregulatory activities of NCAM and N-cadherin can be accounted for by G protein-dependent activation of Land N-type neuronal Ca2+ channels. Cell 67: 21−33.
- Fatemi S.H., Haas R., Jentoft N, Rosenberry T.L. and Tartakoff A.M. (1987). The glycophospholipid anchor of Thy-1. Biosynthetic labeling experiments with wild-type and class E Thy-1 negative lymphomas. J. Biol. Chem. 262(10): 4728−4732.
- Feron O., Smith T.W., Michel T., Kelly R.A.(1997). Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J. Biol. Chem. 272(28): 17 744−17 748
- Feron O., Saldana F., Michel J.B., Michel T. (1998). The endothelial nitric-oxide syntase-caveolin regulatory cycle. J Biol. Chem. 273(6): 3125−3128.
- Fraker P.J. and Speck J.C. (1978). Protein and cell membrane iodinations with a sparingly soluble chloroamide l, 3,4,6-tetrochloro-3a, 6a-diphenylglycoril. Biochem. Biophys. Res.Comm., 80: 849−857.
- Fredette B.J. and Ranscht B. (1994). T-cadherin expession delineates specific regions of the developing motor axon-hindlimb projection pathway. J. Neuroscience 14(12): 7331−7346.
- Fredette B.J. Miller J., Ranscht B. (1996). Inhibition of motor axon growth by T-cadherin substrata. Development 122: 3163−3171.
- Fujimoto T. (1993). Calcium pump of the plasma membrane is localized in caveolae. J. Cell Biol. 120(5): 1147−1157.
- Fujimoto T., Nakade S., Miyawaki A., Mikoshiba K. and Ogawa K. (1992). J. Cell Biol. 119: 1507−1513.
- Galle J., Bassenge E., Busse R. (1990). Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. -Circ. Res. 66(5): 1287−1293.
- Geiger B. and Ayalon O. (1992). Cadherins. Annu. Rev. Cell Biol. 8: 307−332.
- Hahn A.B. and Soloski M.J. (1989). Anti-Qa2 induced T-cell activation. The parameters of activation, the definition of mitogenic and non-mitogenic antibodies and the differential effects of CD4+ vs CD8+ T cells. J.Immunol. 143: 407.
- Hahn A.W.A., Ferracin F., Buhler F.R., Pletscher A. (1991). Modulation of gene expression by high and low density lipoproteins in human vascular smooth muscle cells. -Biochem. Biophys. Res. Comm. 178(3): 1465−1471.
- Harlow E. and Lane D. (1988). Antibodies. A laboratory manual. Cold Spring Harbor Laboratory, USA.
- Havel R.J., Eder H.A., Bragdon H.H. (1955). The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J.Clin.Invest. 34: 13 451 353.
- Hooper N., Low M.G. and Tutner A.J. (1987). Renal dipeptidase is one of the membrane proteins released by phosphatidylinositol-specific phospholipase C. -Biochem. J. 244(2):465−469
- Hooper N.M. (1998). Membrane biology: Do glycolipid microdomains realy exsist? -Current Biology 8: R114-R116.
- Huang J., Makker S.P. (1995). Role of receptor-associated 39/40 kD protein in active Heymann nephritis. Kidney Int. 47(2): 432−441.
- Huang C., Hepler J.R., Chen L.T., Gilman A.G., Anderson R.G.W., Mutby S.M. (1997). Organisation of G Proteins and Adenylyl Cyclase at the Plasma Membrane. Mol. Biol. Cell 8(12): 2365−2378.
- Hui D.Y., Harmony J.A.K., Innerarity T.L., Mahley R.W. (1980). Immunoregulatory plasma lipoproteins. J.Biol.Chem. 255 (24): 11 775−11 781.
- Jacobs M., Plane F., Bruckdorfer K.R. (1990). Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta. Br. J. Pharmacol. 100(1): 21−26.
- Jang Y., Lincoff M., Plow E.F., Topol E.J. (1994). Cell adhesion molecules in coronary artery disease. JACC 24(7): 1591−1601.
- Jiang W.G., Singhrao S.K., Hiscox S., Hallett M B., Bryce R.P., Horrobin D.F., Puntis M.C., Mansel R.E. (1997). Regulation of desmosomal cell adhesion in human tumor cells by polyunsaturated fatty acids. Clin. Exp. Metastasis 15(6): 593−602.
- Kelley J.L., Rozek M.M., Suenram C.A., Schwartz C.J. (1988). Activation of human peripheral blood monocytes by lipoproteins. Am. J. Pathol. 130: 223−231.
- Kiessling R., Gronberg A., Ivanyi J., Sodersrom K., Ferm M., Kleinau S., Nilsson E., Klareskog L. (1991). Role of hsp60 during autoimmune and bacterial inflammation.-Immunol. Rev. 12: 91−111.
- Koch P.J. and Frank W.W. (1994). Desmosomal cadherins: another growing multigene family of adhesion molecules. Current Opinion in Cell Biol. 6: 682−687.
- Kugiyama K., Kerns S.A., Morrisett J.D., Roberts R, Henry P.D. (1990). Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344(6262): 160−162
- Kusimi A. and Sako Y. (1996). Cell surfase organization by the membrane skeleton. -Current Opin. Cell Biol. 8: 566−574.
- Kuzmenko Y.S., Bochkov V.N., Philippova MP., Tkachuk V.A. and Resink T.J. (1994). Characterization of an atypical lipoprotein-binding protein in human aortic media membranes by ligand blotting. Biochem.J.303: 281−287.
- Kusuhara M., Chait A., Cader A., Berk B.C. (1997). Oxidized LDL stimulates mitigen-activated protein kinases in smooth muscle cells and macrophages. -Arteriosclerosis Thrombosis Vascular Biology 17(1): 141−148.
- Laemmli U.K. (1970). Cleavage of structural protein during the assembly of head of bacteriophage T4. Nature 227: 680−685.
- Lee S.W. (1996). H-cadherin, a novel cadherin with growth inhibitory function and diminished expression in human breast cancer. Nature Med. 2(7): 776−782.
- Lee S.W., Reimer C.L., Oh P., Campbell D.B., Schnizer J.E. (1998). Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogen, 16(11): 1391−1397.
- Libby P., Miao P., Ordovas J.M., Schaeffer E.J. (1985). Lipoproteins increase growth of mitogen-stimulated arterial smooth muscle cells.- J. Cell Physiol. 124: 1−8.
- Lisanti, M.P., Tang, Z., Scherer, P.E. and Sargiacomo, M. (1995) Methods Enzymol. 250, 655−668.
- Liu P., Ying Y., Ko Y.G., Anderson R.G. (1996). Localization of platelet-derived growth factor-stimulated phosphorilation cascade to caveolae. J. Biol. Chem. 271(17): 10 299−10 303.
- Low M.G. (1989). The glycosyl-phosphatidylinositol anchor of membrane proteins. -Biochim. Biophys. Acta 988: 427−454.
- Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 261−275.
- Matlib M.A. (1984). Isolation of sarcolemmal membranes from smooth muscle. -Meth.Pharmacol. 5: 13−24.
- Mason I. (1994). Do adhesion molecules signal via FGF receptors? Curr. Biol. 4 (12): 1158−61.
- Matlib M.A. (1984). Isolation of sarcolemmal membranes from smooth muscle. -Meth.Pharmacol. 5: 13−24.
- McEver R.P., (1997). Selectin-carbohydrate interactions during inflamation and metastasis. Glycoconj. 14(5), 585−591.
- Mastick C.C., Brady M.J. and Saltiel A. (1995). Insulin stimulates the tyrosine phosphorilation of caveolin. J. Cell Biol. 129(6): 1523−1531.
- McMurray H.F., Parthasarathy S., Steinberg D. (1993). Oxidatevely modified low density lipoprotein is a chemoattractant for human T -lymphocytes.- J.Clin.Invest. 92: 1004−1008.
- Mendez A.J., Oram J.F., Bierman E.L. (1990). Arteriosclerosis 10: 768a.
- Middleton M. and Middleton B. (1990). Agents which increase cyclic AMP have diverse effects on low-density-lipoprotein-receptor function in human vascular smooth-muscle cells and skin fibroblasts. Biochem. J. 267: 607−614.
- Mohan P.F. and Jacobson M.S. (1995). Effect of lipoprotein on macrophage superoxide generation. Cell Biochem. Funct. 13 (2): 135−140.
- Monier S., Dietzen D.J., Hasting W.R., Lublin D.M., Kurzchalia TV. (1996). Oligomerization of VTP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol.-FEBS Lett. 388(2−3): 143−149.
- Munro S.B., Duclos A.J., Jackson A.R., Baines M.G., Blaschuk O.W. (1996). Characterization of Cadherins expressed by murine thymocytes. Cell Immunol. 169 (2): 309−12.
- Nakabayashi T. and Ikewaza H. (1986). Alkaline phosphodiesterase I release from eucaryotic plasma membranes by phosphatidylinositol-specific phospholipase C. I. The release from rat organs. J. Biochem. (Tokyo), 99(3):703−712.
- Nazih-Sanderson F., Lestavel S., Nion S., Rouy D., Denefle P., Fruchart J.C., Clavey V., Delbart C. (1997). HDL3 binds tj glycosylphosphatidylinositol-anchored proteins to activate signalling pathways. Biochim. Biophis. Acta 1358(1): 103−112.
- Nicholson A.C. and Hajjar D.P. (1992). Transforming growth factor-? up-regulates low density lipoprotein receptor-mediated cholesterol metabolism in vascular smooth muscle cells. J. Boil. Chem. 267(36): 25 982−25 987.
- Nion S., Briand O., Lestavel S., Torpier G., Nazih F., Delbart C., Fruchart J.C. Clavey V. (1997). High density Lipoprotein subtraction 3 interaction with glycophosphatidylinositol-anchored proteins. Biochem. J. 328(2): 415−423.
- Nose A. and Takeichi M. (1986). A novel Cadherin cell adhesion molecule: Its expression patterns associated with implantation and organogenesis of mouse embryos. J. Cell Biol. 103: 2649−2658.
- Nose A., Tsuji K., Takeichi M. (1990). Localization of specifity determining sites in Cadherin cell adhesion molecules. Cell, 61: 147−155.
- O’Farrell P.Z., Goodman H.M., O’Farrell P.H. (1977). Cell 12: 1133.
- Ogata S., Hayashi Y., Takami N. and Ikehara Y. (1988) Chemical characterization of the membrane-anchoring domain of human placental alkaline phosphatase.- J. Biol. Chem. 263 (21): 10 489−10 494
- Oikawa S., Hori S., Sano R., Suzuki N., Fujii Y., Abe R., Goto Y. (1987). Effect of low density lipoprotein on DNA synthesis of cultured human arterial smooth muscle cells. -Atherosclerosis 64: 7−12.
- Oka N., Asai K., Kudej R.K., Edwards J.G., Toya Y., Schwencke C., Vatner D.E., Vatner S.F., Ishikawa Y. (1997). Downregulation of caveolin by chronic beta-adrenergic receptor stimulation in mice. Am. J Physiol. 273(6 Part 1): C1957-C1962.
- Okamoto T., Schlegel A., Scherer P.E., Lisantri M.P. (1998). Caveolins, a family of scaffolding proteins for organizing «preassembled signalling complexes at the plasma membrane. J. Biol. Chem. 273 (10): 5419−5422.
- Ostermann G., Kostner G.M., Gries A., Malle E., Till U. (1989). The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum. -Haemostasis 19: 160−168.
- Overduin M., Harvey T.S., Bagby S., Tong K.I., Yau P., Takeichi M., Ikura M. (1995). Solution structure of the epithelial cadherin domain responsible for selective cell adhesion.- Science 267: 386- 389.
- Ozawa M. and Kemler R. (1990). Correct proteolitic cleavage is required for the cell adhesive function of uvimorulin. J. Cell. Biol. Ill: 1645−1650.
- Ozer N.K., Palozza P., Boscoboinik D., Azzi A. (1993). d-a-Tokopherol inhibits low density liporpotein induced proliferation and protein kinase activity in vascular smooth muscle cells. FEBS Lett. 322: 307−310
- Parhami F., Fang Z.T., Fogelman A.M., Andalibi A., Territo M.C., Berliner J.A. (1993). Minimally modified low density lipoprotein induced inflammatory responses in endothelial cells are mediated by cAMP. J. Clin. Invest. 92: 471−478.
- Parpal S., Gustavsson J. and Stralfors P. (1995) Isolation of phosphooligosaccharide phosphoinositol glycan from caveolae and cytosol of insulin-stimulated cells.- J. Cell Biol. 131: 125−135.
- Parton R.G. (1996). Caveolae and caveolins. Curr. Opin. Cell Biol. 8(4): 542−548.
- Petty H.R., Todd III R.F. (1995). Integrins as promiscuous signal transduction devices. -Trends Immunology Today 17(5): 209−211.
- Pian M.S., Dobbs L.G., (1997). Lipoprotein-stimulated surfactant secretion in alveolar type II cells: mediation by heterotrimeric G proteins. American Journal of Physiology, 273(3 Part l):634−639.
- Pomerantz K.B., Tall A.R., Cannon P.J. (1984). Stimulation of vascular smooth muscle cell prostacyclin and prostaglandin E2 synthesis by plasma high and low density lipoproteins. Circ. Res. 54: 554−565.
- Prusiner S.B. and DeArmond S.J. (1994). Prion diseases and neurodegeneration. Annu. Rev. Neurosci., 17: 311−339.
- Quinn M.T., Parthasarathy S., Fong L.G., Steinberg D. (1987). Oxidatevely modified low density lipoproteins: a potential role in recruitment and retention ofmonocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA, 84: 29 952 998.
- Ranscht B. and Dours-Zimmermann M.T. (1991). T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region. -Neuron 7: 391- 402.
- Ranscht B. and Bronner-Fraser M. (1991). T-cadherin expression alternates with migrating neural crest cells in the trunk of the avian embrio. Development 111: 15−22.
- Ratnoff W.D., Knez J.J., Prince G.M., Okada H., Lachman P.T. and Medof E M. (1992). Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59. Clin. Exp. Immunol. 87 (3): 415−421
- Roberts W.L., Kim B.H., Rosenberry T.L. (1988). Differences in the glycolipid membrane anchors of bovine and human erythrocyte acetylcholinesterases. Proc. Natl. Acad. Sci. USA 84(22):7817−7821.
- Robinson P.J. (1991). Phosphatidylinositol membrane anchors and T-cell activation. -Immunol.Today 12: 35.
- Romero G., Luttrell L., Rogol A., Zeller K., Hewlett E., Larner J. (1988). Phosphatidylinositol-glycan anchors of membrane proteins: potential precursors of insulin mediators. Science 240: 509−511.
- Rosales C., O’Brien V., Kornberg L. and Juliano R. (1995). Signal transduction by cell adhesion receptors. Biochimica et Biophysica Acta, 1242: 77−98.
- Rothberg K.G., Ying Y.S., Kamen B. A., Anderson R.G. (1990). Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J. Cell Biol. 111(6 Pt 2):2931−2938.
- Sacristan M.P., Vestal DJ., Dours-Zimmermann M.T., Ranscht B. (1993). T-cadherin-2: molecular characterization, function in cell adhesion, and coexpression with T-cadherin and N-cadherin.- J. Neuroscience Res. 34 (6): 664−80.
- Sagriacomo M., Sudol M., Tang Z., Lisanti M.P. (1993) Signal transduction molecules and glycosyl-phosphatidylinositol-linked proteins from a caveolin rich insoluble complex in MDCK cells. J Cell Biol. 122(4): 789−807.
- Sandig M., Vourta E.B., Kalnins V.I., Siu C.H. (1997). Role of cadherins in transendotelial migration of melanoma cells in culture. Cell Motil. Cytoskeleton 38(4): 351−364.
- Sano K., Tanihara H., Heimark R.L., Obata S., Davidson M., St. John T., Taketani S., Suzuki S. (1993). Protocadherins: a large family of cadherin-related molecules in central nervous sistem. EMBO J. 12: 2249−2256.
- Schmidt K., Graier W.F., Kostner G.M., Mayer B., Kukovetz W.R. (1990). Activation of soluble guanylate cyclase by nitrovasodilators is inhibited by oxidized low-density lipoprotein. Biochem Biophys Res. Commun. 172(2):614−619.
- Schmidt J.W., Piepenhagen P.A., Nelson W.J. (1993). Modulation of epithelial morphogenesis and cell fate by cell-to-cell signals and regulated cell adhesion. Seminars in Cell Biol. 4 (3): 161−173.
- Scott-Burden T., Resink T.J., Hahn A.W.A., Baur U., Box R.J., Buhler F.R. (1989). Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. J. Biol. Chem. 21: 12 582−12 589.
- Seed B., (1987). An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2. Nature (London), 329(6142): 840−842.
- Siegel G. and Malmstein M. (1997). The role of the endotelium in inflammation and tumor metastasis. Int. J. Microcirc. Clin. Exp. 17(5): 257−272.
- Simons K. and Ikonen E. (1997) Functional rafts in cell membranes. Nature 387: 569 572.
- Singer S.J. and Nicolson G.L. (1972) The fluid mosaic model of the structure of cell membranes. Scince 175: 720−731.
- Smart E.J., Ying Ys., Donzel W.C., Anderson R.G., (1997). A role of caveolin in transport of cholesterin fron endoplasmatic reticulum to plasma membrane. J. Biol. Chem., 271(46): 29 427−29 435.
- Solomon K.R., Rudd C.E., Finberg R.W. (1996). The association between glycosylphosphatidylinositol-anchored proteins and heterotrimeric G protein alpha subunits in lymphocytes. Proc. Natl. Acad. Sci. USA. 93(12): 6053−6058.
- Song K.S., Li S., Okamoto T., Quilliam L.A., Sagriacomo M., Lisanti M.P. (1996). Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. J. Biol. Chem. 271(16): 9690−9697.
- Stafforini D.M., Prescott S.M., Mclntyre T.M. (1987). Human plasma platelet-activating factor acetylhydrolase. J. Biol. Chem. 262: 4223- 4230.
- Stahl A., Mueller B.M. (1995) The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J Cell Biol. 129(2): 335−344.
- Stefanova I., Horejsi V., Ansotegui I.J., Knapp W., Stockinger H. (1991). GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254: 1016- 1019.
- Taguchi R. and Ikewaza H. (1978). Phosphatidyl inositol-specific phospholipase C from Clostridium novyi type A. Arch. Biochem Biophys. 186(1): 196−201.
- Takasue I., Yokota K., Nishi Y., Taguchi R. and Ikewaza H. (1986). Solubilization of trehalase from rabbit renal and intestinal brush-border membranes by a phosphatidylinositol-specific phospholipase C. FEBS Lett. 244(2):465−469.
- Takeichi M. (1990) Cadherins: a molecular family important in selective cell-cell adhesion. Annu. Rev. Biochem. 59: 237−252.
- Takeichi M. (1991). Cadherin cell adhesion receptors as a morphogenic regulator. -Science 251: 1451−1455.
- Tan W., Barnett J.V., Pietrobon D., Hehn G., Greiser C., Marsh J.D., Galper J.B. (1993). Effect of low-density lipoproteins, mevinolin, and G proteins on Ca2+ response in cultured chick atrial cells. Heart. Circ. Physiol. 34: H191-H197.
- Thomas J.R., Dwek R.A., Rademacher T.W. (1990). Structure, biosynthesis and function of glycosylphosphatidylinositols. Biochemistry 29 (23): 5413−5422.
- Thompson L.F., Luedi J.M., Glass A., Low M.G., and Lucas A.H. (1989). Antibodies to 5'-nucleotidase (CD73), a glycosyl-phosphatidylinositol anchored protein, cause human peripheral blood T cells to proliferate. J. Immunol. 143: 1815.
- Tkachuk V.A., Kuzmenko Y.S., Resink T.J., Stambolsky D.V., Bochkov V.N. (1994). Atypical low density lipoprotein binding site that may mediate lipoprotein-induced signal transduction. Molec.Pharmacol. 46: 1129−1137.
- Towbin H» Staehelin T" Gordon G. (1979).- Proc. Natl. Acad. Sci. USA 76: 43 504 354.
- Toya Y., Schwencke C., Couet J., Lisanti M.P., Ishikawa Y. (1998). Inhibition of adenylyl cyclase by caveolin peptides. Endocrinology 139(4): 2025−2031.
- Triau J.E., Meydani S.N., Schaefer E.J. (1988). Oxidized low density lipoprotein stimulates prostacyclin production by adult human vascular endothelial cells. -Arterioscler. 8: 810−818.
- Van Meer G. (1989). Lipid traffic in animal cells. Rev. Cell Biology 5: 247−275.
- Venema V.J., Ju H., Zou R., Venema R.C. (1997). Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol. Chem. 272(45): 28 187−28 190.
- Vestal D.J. and Ranscht B. (1992). Glycosyl phosphatidylinositol anchored T-cadherin mediates calcium-dependent, homophilic cell adhesion. — J. Biol. Chem. 119 (2): 451 461.
- Vivien D., Petitfrere E., Martiny L., Sartelet H., Galera P., Haye B., Pujol IP. (1993). IPG (inositolphosphate glycan) as a cellular signal for TGF-pi modulation of chodrocyte cell cycle. J. Cell.Physiol. 155: 437−444.
- Voyno-Yasenetskaya T.A., Dobbs L.G., Erickson S.K., Hamilton R.L. (1993). Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells. Proc. Natl. Acad. Sci. USA 90: 4256−4260.
- Wagner G. (1995). E-cadherin: a distant member of immunoglobulin superfamily. -Science 267(5196): 342.
- Weisser B., Locher R., Lehmann E., de Graaf J., Vetter W. (1993). Proliferative effects of low density lipoprotein subfractions on vascular smooth muscle cells: Potentiation by insulin.-J. Hypertens. ll (suppl.5): S126-S127.